Abstract
BackgroundHepatitis C virus (HCV), either alone or in combination with Human Immunodeficiency virus (HIV), constitutes a major public health concern. This study was conducted to describe the prevalence and risk factors for HCV infection in people with and without HIV infection.MethodsBlood samples and data on socio-demographic and risk factors for HCV infection were collected from consecutive 400 HIV- positive and 400 HIV- negative individuals attending HIV testing centers in Hawassa city, from October to December, 2008. All sera were tested for antibody to HCV infection (anti-HCV) using enzyme linked immunosorbent assay (ELISA). Sera positive for anti-HCV were further tested for viral ribonucleic acid (RNA) levels using real-time polymerase chain reaction.ResultsThe rate of anti-HCV positivity was 10.5% in the HIV- infected individuals compared with 6% in the HIV negative group (p = 0.002). HCV-RNA was detected in 9.1% of anti-HCV positive samples and rates were comparable between HIV- infected and HIV- non-infected individuals. There was no significant difference in odds of HCV infection in participants with and without HCV risk factors in either HIV sero-group.ConclusionHIV infected individuals had significantly higher rate of anti-HCV although most of them showed no evidence of viraemia. Hence, while priority should be given for HIV infected patients, testing those with anti-HCV for HCV-RNA remains important.
Highlights
Hepatitis C virus (HCV) represents a major public health burden in both industrialized and developing countries
The prevalence of anti-HCV in Human Immunodeficiency virus (HIV)-positive individuals was 10.5% compared to 6% in HIV-negative individuals (p = 0.002) (Table 2)
A comparable rate of antiHCV marker was observed in HIV-infected individuals with or without antiretroviral therapy (ART)
Summary
Hepatitis C virus (HCV) represents a major public health burden in both industrialized and developing countries. The prevalence of HCV infection is estimated to be 2.2-3.0% (130-170 million people) worldwide [1]. Region-specific estimates range from < 1.0% in Northern Europe to > 2.9% in Northern Africa, with the highest prevalence (15%-20%) reported in Egypt [2]. About 15 to 20% of HCV infections progress to potentially serious cirrhosis and end-stage liver disease [3]. Due to shared mode of transmission, co-infection of HCV and human immunodeficiency virus (HIV) has become a growing public health concern. Hepatitis C virus (HCV), either alone or in combination with Human Immunodeficiency virus (HIV), constitutes a major public health concern. This study was conducted to describe the prevalence and risk factors for HCV infection in people with and without HIV infection
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.